Clinical Trials Logo

Clinical Trial Summary

To observe the safety and efficacy of ImageReady™ MR Conditional Pacing System in Chinese subjects


Clinical Trial Description

Key Inclusion Criteria:

1. Subject must have the Image Ready System as their initial (de novo) pacing system implant.

2. Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines.

3. Subject is able and willing to undergo an MR scan.•

4. Subject is willing and capable of providing informed consent and participating in all testing/ visits associated with this clinical study at the intervals defined by this protocol.

5. Subject is age 18 or above.

Key Exclusion Criteria

1. Subject has or has had any pacing or ICD system implants.

2. Subject has any implants or devices that are not suitable for MR scan.

3. Subject is enrolled in any other concurrent study that might interfere with this study.

4. Subject has documented life expectancy of less than 12 months.

5. Women of childbearing potential who are or might be pregnant at the time of this study.

Primary Safety Endpoint:

MR Scan related Complication Free Rate Analyzed at MRI Visit +1 Month.

Primary efficacy Endpoint:

1. Pacing Threshold (at 0.5 ms pulse width) comparison pre and 1 Month post MR Scan: pacing threshold increase ≤ 0.5 V after scan.

2. Sensed Amplitude comparison pre- and 1 Month post-MR Scan: sensed amplitude: ≥ 1.0 mV after scan, and ≥ 50% of that before scan. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02636712
Study type Observational
Source Boston Scientific Corporation
Contact
Status Completed
Phase
Start date December 8, 2015
Completion date November 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05621460 - The Effect of Water Carbonation on Orthostatic Tolerance N/A
Active, not recruiting NCT02123056 - Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Phase 4
Completed NCT02140567 - Syncope Prediction Study
Active, not recruiting NCT01456481 - Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV Phase 4
Completed NCT00061009 - Hypnosis in Autonomic Function N/A
Recruiting NCT06331819 - Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
Recruiting NCT05159687 - Study of Atomoxetine in the Prevention of Vasovagal Syncope Phase 3
Completed NCT02500732 - Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope Phase 2
Recruiting NCT02018497 - Essential Hypotension and Allostasis Registry
Recruiting NCT03446326 - Assessment of Stroke Volume and Cardiac Output in Response to Varying Heart Rates N/A
Active, not recruiting NCT01791816 - Mechanisms of Vasovagal Syncope Early Phase 1
Completed NCT00292825 - Effect of Closed Loop Pacemaker Treatment on Recurrent Vasovagal Syncope N/A
Completed NCT02949804 - Relation Between Vasovagal Tendency and Smoking Among University Students N/A
Completed NCT02009982 - Cardioneuroablation for Neurocardiogenic Syncope N/A
Not yet recruiting NCT06166277 - Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry